Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. on August 5, 2024, covering events occurring on July 31, 2024, and August 2, 2024. The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbols CELU (Class A Common Stock) and CELUW (Warrants).
Key Financial Metrics
This filing does not contain specific revenue, profit, cash flow, or debt figures. However, it references prior financial statements for the years ended December 31, 2023, and 2022, which included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
Material Changes
- Dismissal of Auditor: On August 2, 2024, the Audit Committee dismissed Deloitte & Touche LLP as the independent registered public accounting firm, effective immediately. Deloitte's prior reports did not contain adverse opinions or disclaimers, though they noted going concern uncertainties.
- Engagement of New Auditor: On August 2, 2024, the Audit Committee engaged EisnerAmper LLP to audit the consolidated financial statements for the year ending December 31, 2024. EisnerAmper will also commence work on unaudited interim statements for the quarters ended March 31, 2024, and June 30, 2024.
- Board Departure: On July 31, 2024, Marc Mazur, a Class III member of the Board of Directors, resigned from the board and all committees. The resignation was not due to any disagreement with the company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance or management commentary on future performance. The primary risk highlighted is the historical "substantial doubt" regarding the company's ability to continue as a going concern, as noted in the 2022 and 2023 financial statements. The company confirmed there were no disagreements with the former auditor regarding accounting principles or audit scope.
Key Facts for Investor Verification
- Verify the rationale for dismissing Deloitte & Touche LLP and the transition plan with EisnerAmper LLP.
- Review the most recent Form 10-K or 10-Q to assess the current status of the "going concern" warning.
- Confirm the composition of the Board of Directors following the resignation of Marc Mazur.
- Monitor upcoming filings (Form 10-Q) for the interim periods ending March 31, 2024, and June 30, 2024, which will be audited by the new firm.